Uremic cardiomyopathy and insulin resistance: a critical role for akt?
David Semple1, Katie Smith, Sunil Bhandari
1Department of Biological Sciences, University of Hull, Kingston-upon-Hull, HU6 7RX, UK.
Abstract:
Uremic cardiomyopathy is a classic complication of chronic renal failure whose cause is unclear and treatment remains disappointing. Insulin resistance is an independent predictor of cardiovascular mortality in chronic renal failure. Underlying insulin resistance are defects in insulin signaling through the protein kinase, Akt. Akt acts as a nodal point in the control of both the metabolic and pleiotropic effects of insulin. Imbalance among these effects leads to cardiac hypertrophy, fibrosis, and apoptosis; less angiogenesis; metabolic remodeling; and altered calcium cycling, all key features of uremic cardiomyopathy. Here we consider the role of Akt in the development of uremic cardiomyopathy, drawing parallels from models of hypertrophic cardiac disease.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
Diabetic Nephropathy
cAMP-dependent Protein Kinase Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Type II Diabetes II: Pathophysiology
